ARK Investment Management LLC
Institutional investor · Portfolio as of Q3 2019
Top Holdings224 positions
Stock | Shares | Value | Weight | Avg Buy | Est. P&L | Held | Conviction |
|---|---|---|---|---|---|---|---|
TESLA INC | 1.2M | $282.4M | 6.2% | $18.60 | -13.22% | 4 qtrssince 2018-Q4 | Increased 60 |
FMS Enterprises Migun Ltd | 16,259 | $221.6M | 4.8% | — | — | 3 qtrssince 2019-Q1 | Increased 56 |
BLOCK INC | 3.4M | $212.1M | 4.6% | $59.00 | +2.97% | 4 qtrssince 2018-Q4 | Increased 73 |
ILLUMINA INC | 695,310 | $211.5M | 4.6% | $300.31 | -2.41% | 4 qtrssince 2018-Q4 | Increased 71 |
Fattal Holdings 1998 Ltd | 3,722 | $195.9M | 4.3% | — | — | 1 qtr | New 85 |
| 7,734 | $188.2M | 4.1% | — | — | 1 qtr | New 84 | |
Bet Shemesh Engines Holdings 1 | 14,616 | $185.8M | 4.1% | — | — | 2 qtrssince 2019-Q2 | Decreased 0 |
MATRIX IT LTD. | 29,508 | $174.7M | 3.8% | — | — | 1 qtr | New 84 |
STRATASYS LTD | 7.8M | $166.3M | 3.6% | $19.25 | +9.93% | 4 qtrssince 2018-Q4 | Increased 56 |
Partner Communications Company | 96,284 | $163.2M | 3.6% | — | — | 1 qtr | New 84 |
| 6,836 | $161.8M | 3.5% | — | — | 4 qtrssince 2018-Q4 | Decreased 0 | |
INVITAE CORP | 7.8M | $151.1M | 3.3% | — | — | 4 qtrssince 2018-Q4 | Decreased 0 |
CRISPR THERAPEUTICS AG | 2.8M | $114M | 2.5% | $34.45 | +22.95% | 4 qtrssince 2018-Q4 | Increased 53 |
INTELLIA THERAPEUTICS INC | 8.5M | $113.1M | 2.5% | $13.66 | -2.25% | 4 qtrssince 2018-Q4 | Increased 53 |
EDITAS MEDICINE INC | 4.9M | $112.2M | 2.4% | $22.15 | +1.55% | 4 qtrssince 2018-Q4 | Increased 52 |
NVIDIA CORP | 530,506 | $92.3M | 2.0% | $3.64 | +17.16% | 4 qtrssince 2018-Q4 | Decreased 0 |
2U INC | 5.1M | $82.6M | 1.8% | — | — | 4 qtrssince 2018-Q4 | Increased 76 |
SPLUNK INC | 667,462 | $78.7M | 1.7% | — | — | 4 qtrssince 2018-Q4 | Increased 60 |
XILINX INC | 810,328 | $77.7M | 1.7% | — | — | 4 qtrssince 2018-Q4 | Increased 70 |
NANOSTRING TECHNOLOGIES INC | 3.4M | $72.4M | 1.6% | — | — | 4 qtrssince 2018-Q4 | Decreased 0 |
ARK Investment Management LLC manages $4.6B across 224 positions as of Q3 2019. Top holdings: TSLA (6.2%), FTCFF (4.8%), XYZ (4.6%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 3.5/5.0.
Active quarter - 38 new positions, 43 exits, 87 increased. Top move: FATLF (NEW, conviction 85). Portfolio: $4.6B across 224 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer